A quantitative reverse transcriptase-polymerase chain reaction assay to identify metastatic carcinoma tissue of origin

Journal of Molecular Diagnostics

Volumn 8, Issue 3, 2006, Pages 320-329

  Talantov, Dimitri ^a   Baden, Jonathan ^a   Jatkoe, Tim ^a   Hahn, Kristina ^a   Yu, Jack ^a   Rajpurohit, Yashoda ^a   Jiang, Yiqiu ^a   Choi, Chang ^a   Ross, Jeffrey S ^b   Atkins, David ^a   Wang, Yixin ^a   Mazumder, Abhijit ^a  

^a Veredix LLC   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; PARAFFIN; RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER TISSUE; CARCINOMA; COLON CARCINOMA; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GENE EXPRESSION PROFILING; GENETIC ALGORITHM; GENETIC DATABASE; HUMAN; HUMAN TISSUE; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; NUCLEOTIDE SEQUENCE; OVARY CARCINOMA; PANCREAS CARCINOMA; PREDICTION; PROSTATE CARCINOMA; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; VALIDATION PROCESS;

EID: 33746028189     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.2353/jmoldx.2006.050136     Document Type: Article

References (44)

1. Ghosh L, Dahut W, Kakar S, Posadas EM, Torres CG, Cancel-Santiago R, Ghosh BC: Management of patients with metastatic cancer of unknown primary. Curr Probl Surg 2005, 42:12-66
2. Mintzer DM. Warhol M, Martin A-M, Greene G: Cancer of unknown primary: changing approaches, a multidisciplinary case presentation from the Joan Karnell Cancer Center of Pennsylvania Hospital. Oncologist 2004, 9:330-338
3. Greco FA, Rodriguez GI, Shaffer DW, Hermann R, Litchy S. Yardley DA, Burris HA III. Morrissey LH, Erland JB, Hainsworth JD: Carcinoma of unknown primary site: sequential treatment with paclitaxel/carboplatin/ etoposide and gemcitabine/irinotecan. A Minnie Pearl cancer research network phase II trial. Oncologist 2004, 9:644-652
4. Brown RW, Campagna LB, Dunn JK, Cagle PT: Immunohistochemical identification of tumor markers in metastatic adenocarcinoma: a diagnostic adjunct in the determination of primary site. Am J Clin Pathol 1997, 107:12-19
5. DeYoung BR, Wick MR: Immunohistologic evaluation of metastatic carcinomas of unknown origin: an algorithmic approach. Semin Diagn Pathol 2000. 17:184-193
6. Dennis JL, Hvidsten TR, Wit EC, Komorowski J, Bell AK, Downie I, Mooney J, Verbeke C, Bellamy C, Keith WN, Oien KA: Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm. Clin Cancer Res 2005, 11:3766-3772
7. Pavlidis N, Briasoulis E, Hainsworth J, Greco FA: Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Can 2003, 39:1990-2005
8. Varadhachary GR, Abbruzzese JL, Lenzi R: Diagnostic strategies for unknown primary cancer. Cancer 2004, 100:1776-1785
9. Dennis JL, Oien KA: Hunting the primary: novel strategies for defining the origin of tumors. J Pathol 2005, 205:236-247
10. Su Al, Welsh JB, Sapinoso LM, Kern SG, Dimtrov P, Lapp H, Schultz PG, Powell SM. Moskaluk CA, Frierson HF Jr, Hampton GM: Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res 2001, 61:7388-7393
11. Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang C-H, Angelo M. Ladd C, Reich M, Latulippe E, Mesirov JP, Poggio T, Gerald W, Loda M, Lander ES, Golub TR: Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA 2001, 98:15149-15154
12. Bloom G, Yang IV, Boulware D, Kwong KY, Coppola D, Eschrich S, Quackenbush J, Yeatman TJ: Multi-platform, multi-site, microarray-based human tumor classification. Am J Pathol 2004, 164:9-16
13. Lewis F, Maughan NJ, Smith V, Hillan K, Quirke P: Unlocking the archive-gene expression in paraffin-embedded tissue. J Pathol 2001, 195:66-71
14. Masuda N, Ohnishi T, Kawamoto S, Monden M, Okubo K: Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples. Nucleic Acids Res 1999, 27:4436-4443
15. Abrahamsen HN, Steiniche T, Nexo E, Hamilton-Dutoit SJ, Sorensen BS: Towards quantitative mRNA analysis in paraffin-embedded tissues using real-time reverse transcriptase-polymerase chain reaction. J Mol Diagn 2003, 5:34-41
16. Specht K, Richter T, Muller U, Walch A, Werner M, Hofler H: Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue. Am J Pathol 2001, 158:419-429
17. Godfrey TE, Kim S-H, Chavira M, Ruff DW, Warren RS, Gray JW, Jensen RH: Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5′ nuclease quantitative reverse transcription-polymerase chain reaction. J Mol Diagn 2000, 2:84-91
18. Cronin M, Pho M, Dutta D, Stephans JC, Shak S, Kiefer MC, Esteban JM, Baker JB: Measurement of gene expression in archival paraffin-embedded tissue. Am J Pathol 2004, 164:35-42
19. Ramaswamy S: Translating cancer genomics into clinical oncology. N Engl J Med 2004. 350:1814-1816
20. Dennis JL. Vass JK, Wit EC, Keith WN, Oien KA: Identification from public data of molecular markers of adenocarcinoma characteristic of the site of origin. Cancer Res 2002, 62:5999-6005
21. Buckhaults P, Zhang Z, Chen Y-C, Wang T-L, St. Croix B, Saha S, Bardelli A, Morin PJ, Polyak K, Hruban RH, Velculescu VE, Shih I-M: Identifying tumor origin using a gene expression-based classification map. Cancer Res 2003, 63:4144-4149
22. Tothill RW, Kowalczyk A, Rischin D, Bousioutas A, Haviv I, van Laar RK, Waring PM, Zalcberg J, Ward R, Biankin AV, Sutherland RL, Henshall SM, Fong K, Pollack JR, Bowtell DDL, Holloway AJ: An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin. Cancer Res 2005, 65:4031-4040
23. Argani P, Rosty C, Reiter RE, Wilentz RE, Murugesan SR, Leach SD, Ryu B, Skinner HG, Goggins M, Jaffee EM, Yeo CJ, Cameron JL, Kern SE, Hruban RH: Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Cancer Res 2001, 61:4320-4324
24. Backus J. Laughlin T, Wang Y, Belly R, White R, Baden J, Min CJ, Mannie A, Tafra L, Atkins D, Verbanac KM: Identification and characterization of optimal gene expression markers for detection of breast cancer metastasis. J Mol Diagn 2005, 7:327-336
25. Cunha AC. Weigle B, Kiessling A, Bachmann M, Rieber EP: Tissue-specificity of prostate specific antigens: comparative analysis of transcript levels in prostate and non-prostatic tissues. Cancer Lett 2006, 236:229-238
26. Borgono CA, Michael IP, Diamandis EP: Human tissue kallikreins: physiologic roles and applications in cancer. Mol Cancer Res 2004, 2:257-280
27. McCarthy DM, Maitra A, Argani P, Rader AE, Faigel DO, Van Heek NT, Hruban RH, Wilentz RE: Novel markers of pancreatic adenocarcinoma in fine-needle aspiration: mesothelin and prostate stem cell antigen labeling increases accuracy in cytologically borderline cases. Appl Immunohistochem Mol Morphol 2003, 11:238-243
28. Hwang H, Quenneville L, Yaziji H, Gown AM: Wilms tumor gene product: sensitive and contextually specific marker of serous carcinomas of ovarian surface epithelial origin. Appl Immunohistochem Mol Morphol 2004, 12:122-126
29. Fleming TP, Watson MA: Mammaglobin, a breast-specific gene, and its utility as a marker for breast cancer. Ann NY Acad Sci 2000, 923:78-89
30. Nakamura N, Miyagi E, Murata S, Kawaoi A, Katoh R: Expression of thyroid transcription factor-1 in normal and neoplastic lung tissues. Mod Pathol 2002, 15:1058-1067
31. Khoor A, Whitsett JA, Stahlman MT, Halter SA: Expression of surfactant protein B precursor and surfactant protein B mRNA in adenocarcinoma of the lung. Mod Pathol 1997, 10:62-67
32. Prasad NB, Biankin AV, Fukushima N, Maitra. A, Dhara S, Elkahloun AG, Hruban RH, Goggins M, Leach SD: Gene expression profiles in pancreatic intraelpithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells. Cancer Res 2005, 65:1619-1626
33. Ishikawa M, Yoshida K, Yamashita Y, Ota J, Takada S, Kisanuki H, Koinuma K, Choi YL, Kaneda R, Iwao T, Tamada K, Sugano K, Mano H: Experimental trial for diagnosis of pancreatic ductal carcinoma based on gene expression profiles of pancreatic ductal cells. Cancer Sci 2005, 96:387-393
34. Fukushima N, Sato N. Prasad N, Leach SD, Hruban RH, Goggins M: Characterization of gene expression in mucinous cystic neoplasms of the pancreas using oligonucleotide microarrays. Oncogene 2004, 23:9042-9051
35. Jones LE, Humphreys MJ, Campbell F, Neoptolemos JP, Boyd MT: Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival. Clin Cancer Res 2004, 10:2832-2845
36. Moniaux N, Andrianifahanana M, Brand RE, Batra SK: Multiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy. Br J Cancer 2004, 91:1633-1638
37. Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, Ladd C, Beheshti J, Bueno R, Gillette M, Loda M, Weber G, Mark EJ, Lander ES, Wong W, Johnson BE, Golub TR, Sugabaker DJ, Meyerson M: Classification of human lung adenocarcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 2001, 98:13790-13795
38. Weigelt B, Glas AM, Wessels LFA, Witteveen AT, Peterse JL, van't Veer LJ: Gene expression profiles of primary breast tumors maintained in distant metastases. Proc Natl Acad Sci USA 2003, 100:15901-15905
39. Lam JS, Yamashiro J. Shintaku IP, Vessella RL, Jenkins RB, Horvath S, Said JW, Reiter RE: Prostate stem cell antigen is overexpressed in prostate cancer metastases. Clin Cancer Res 2005, 11:2591-2596
40. van Ruissen F, Ruijter JM, Schaaf GJ, Asgharnegad L, Zwijnenburg DA, Kool M, Baas F: Evaluation of the similarity of gene expression data estimated with SAGE and Affymetrix Gene Chips. BMC Genomics 2005, 6:91
41. Kim HL: Comparison of oligonucleotide-microarray and serial analysis of gene expression (SAGE) in transcript profiling analysis of megakaryocytes derived from CD34+ cells. Exp Mol Med 2003, 35:460-466
42. Mikhitarian K, Reott S, Hoover L, Allen A, Cole DJ, Gillanders WE, Mitas M: Enhanced detection of RNA from paraffin-embedded tissue using a panel of truncated gene-specific primers for reverse transcription. BioTechniques 2004, 36:1-4
43. Chung CH, Parker JS, Karaca G, Wu J, Funkhouser WK, Moore D, Butterfoss D, Xiang D, Zanation A, Yin X, Shockley WW, Weisser MC, Dressler LG, Shores CG, Yarbrough WG, Perou CM: Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 2004, 5:489-500
44. Takamura M, Sakamoto M, Ino Y, Shimamura T, Ichida T, Asakura H, Hirohashi S: Expression of liver-intestine cadherin and its possible interaction with galectin-3 in ductal adenocarcinoma of the pancreas. Cancer Sci 2003, 94:425-430